RESUMEN
BACKGROUND: Systemic delivery of anti-tumor therapeutic agents to brain tumors is thwarted by the blood-brain barrier (BBB), an organotypic specialization of brain endothelial cells (ECs). A failure of pharmacological compounds to cross BBB is one culprit for the dismal prognosis of glioblastoma (GBM) patients. Identification of novel vascular targets to overcome the challenges posed by the BBB in tumors for GBM treatment is urgently needed. METHODS: Temozolomide (TMZ) delivery was investigated in CT2A and PDGFB-driven RCAS/tv-a orthotopic glioma models. Transcriptome analysis was performed on ECs from murine gliomas. Mfsd2a deficient, Cav1 deficient, and Mfsd2a EC-specific inducible mice were developed to study the underlying molecular mechanisms. RESULTS: We demonstrated that inhibiting Wnt signaling by LGK974 could increase TMZ delivery and sensitize glioma to chemotherapy in both murine glioma models. Transcriptome analysis of ECs from murine gliomas revealed that Wnt signaling inhibition enhanced vascular transcytosis as indicated by the upregulation of PLVAP and downregulation of MFSD2A. Mfsd2a deficiency in mice enhances TMZ delivery in tumors, whereas constitutive expression of Mfsd2a in ECs suppresses the enhanced TMZ delivery induced by Wnt pathway inhibition in murine glioma. In addition, Wnt signaling inhibition enhanced caveolin-1 (Cav1)-positive caveolae-mediated transcytosis in tumor ECs. Moreover, Wnt signaling inhibitor or Mfsd2a deficiency fails to enhance TMZ penetration in tumors from Cav1-deficient mice. CONCLUSIONS: These results demonstrated that Wnt signaling regulates MFSD2A-dependent TMZ delivery through a caveolae-mediated EC transcytosis pathway. Our findings identify Wnt signaling as a promising therapeutic target to improve drug delivery for GBM treatment.
Asunto(s)
Neoplasias Encefálicas , Glioblastoma , Glioma , Simportadores , Ratones , Animales , Vía de Señalización Wnt , Células Endoteliales/metabolismo , Glioma/tratamiento farmacológico , Glioma/metabolismo , Temozolomida/uso terapéutico , Glioblastoma/patología , Neoplasias Encefálicas/patología , Transcitosis , Línea Celular Tumoral , Resistencia a Antineoplásicos , Simportadores/metabolismo , Simportadores/uso terapéuticoRESUMEN
PURPOSE: Glioblastoma (GBM) is the most aggressive and lethal type of brain tumors. Magnetic resonance imaging (MRI) has been commonly used for GBM diagnosis. Contrast enhancement (CE) on T1-weighted sequences are presented in nearly all GBM as a result of high vascular permeability in glioblastomas. Although several radiomics studies indicated that CE is associated with distinct molecular signatures in tumors, the effects of vascular endothelial cells, the key component of blood brain barrier (BBB) controlling vascular permeability, on CE have not been thoroughly analyzed. METHODS: Endothelial cell enriched genes have been identified using transcriptome data from 128 patients by a systematic method based on correlation analysis. Distinct endothelial cell enriched genes associated with CE were identified by analyzing difference of correlation score between CE-high and CE-low GBM cases. Immunohistochemical staining was performed on in-house patient cohort to validate the selected genes associated with CE. Moreover, a survival analysis was conducted to uncover the relation between CE and patient survival. RESULTS: We illustrated that CE is associated with distinct vascular molecular imprints characterized by up-regulation of pro-inflammatory genes and deregulation of BBB related genes. Among them, PLVAP is up-regulated, whereas TJP1 and ABCG2 are down-regulated in the vasculature of GBM with high CE. In addition, we found that the high CE is associated with poor prognosis and GBM mesenchymal subtype. CONCLUSION: We provide an additional insight to reveal the molecular trait for CE in MRI images with special focus on vascular endothelial cells, linking CE with BBB disruption in the molecular level. This study provides a potential new direction that may be applied for the treatment optimization based on MRI features.
RESUMEN
Currently, little attention has been paid to reducing carbon dioxide (CO2) emissions of Gansu, and the two-dimensional decoupling model has been rarely used to study the relationship between the economic development and CO2 emissions, especially in western China (e.g., Gansu). Thus, here, we first used the Logarithmic Mean Divisia Index (LMDI) to decompose the driving factors of Gansu's CO2 emissions between 2000-2017 and then analyzed the decoupling relationship by using the two-dimensional model. Results showed: (1) Gansu's CO2 emissions increased from 7805.70 × 104 t in 2000 to 19,896.05 × 104 t in 2017. The secondary industry accounted for the largest proportion in Gansu's CO2 emissions, followed by the tertiary industry and the primary industry. (2) The economic output showed the dominant driving effect on Gansu's CO2 emissions growth with the cumulative contribution rate of 201.94%, followed by the effects of industrial structure, population size, and energy structure, and their cumulative contribution rates were 9.68%, 7.81%, and 3.05%, respectively. In contrast, the energy intensity effect presented the most obvious mitigating effect with the cumulative contribution rate of -122.49%. (3) The Environmental Kuznets Curve (EKC) between CO2 emissions and economic growth was demonstrated the inverted U-shape in Gansu. The two-dimensional decoupling status was the low level-weak decoupling (WD-LE) during 2000-2017. Thus, dropping the proportion of the secondary industry, reducing the use of carbon-intensive fuel like coal, introducing advanced technologies, and increasing the investment of new energy might effectively restrain the growth of Gansu's CO2 emissions.